Navigation Links
Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation
Date:1/12/2009

anticipate," "expect," intend," "outlook," "believe" and other similar expressions are intended to identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. These forward-looking statements are based on estimates and assumptions by our management that, although we believe to be reasonable, are inherently uncertain and subject to a number of risks and uncertainties.

The following represent some, but not necessarily all, of the factors that could cause actual results to differ from historical results or those anticipated or predicted by our forward-looking statements: our substantial indebtedness; competitive factors in the industry in which we operate (including the approval and introduction of generic or branded products that compete with our products); our ability to protect our intellectual property; a delay in qualifying our manufacturing facility to produce our products or production or regulatory problems with either third party manufacturers upon whom we may rely for some of our products or our own manufacturing facility; pricing pressures from reimbursement policies of private managed care organizations and other third party payors, government sponsored health systems, the continued consolidation of the distribution network through which we sell our products, including wholesale drug distributors and the growth of large retail drug store chains; the loss of key senior management or scientific staff; adverse outcomes in our outstanding litigation or an increase in the number of litigation matters to which we are subject; government regulation affecting the development, manufacture, marketing and sale of pharmaceutical products, including our ability and the ability of companies with whom we do business to obtain necessary regulatory approvals; our ability to manage the growth of our business by successfully identifying,
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.; Warner Chilcott Limited
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco
2. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
3. Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007
4. Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference
5. Warner Chilcott to Present at the 2008 Wachovia Healthcare Conference
6. Warner Chilcott Announces 2008 Financial Guidance
7. Pinstripe Healthcare Group Adds Veteran HR Executive Warner as Client Services Director
8. Sharing Miracles Television Program to Feature Mountain Climber and Cancer Survivor Sean Swarner
9. CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecoms IP VPN
10. LodgeNet Appoints John E. Haire, Former Time Warner Executive, to Board of Directors
11. Warner Chilcott Announces Settlement of Securities Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Canadian Healthy Vending ... Vending Machines, and that's in sync with the preference ... the Canada Organic Trade Association (COTA). The report says ... beverages each year. This makes the burgeoning organic market ... , As a Canadian leader in healthy vending machines, ...
(Date:5/23/2013)... OnSomble, Inc. has partnered with The Aroostook Medical ... and empower nurses to work at their full capacity. ... services and chief nursing officer at The Aroostook Medical ... want to help them take the next step in ... follow, encourage them to take pride in being a ...
(Date:5/23/2013)... Great defined abs are the embodiment of being ... achieve in the gym yet so many fall short of ... goal become a reality. Great abdominal muscles are acquired in ... Scott Tischler of Tischler Brothers Fitness explains four of these ... of great abs. , 1.    Go to bed early. The body ...
(Date:5/23/2013)... Better Life Maids of Portland Oregon is putting on the ... of a kind green house cleaning service in the Portland ... 29th, and a soft opening scheduled for June 3rd, 2013. ... Portland recently and will travel to St. Louis June 26th ... is a lot to take in" stated Heather Richardson. "Better ...
(Date:5/23/2013)... Pittsburgh-based company Automated Security Alert focuses ... own homes for as long as possible. Jason ... commented on how the company differs from other medical ... are numerous companies in the United States that offer ... they are dedicated only to health and well-being while ...
Breaking Medicine News(10 mins):Health News:Max! Healthy Vending Machines in Tune with Burgeoning Organic Foods Market 2Health News:OnSomble, Inc. Partners with The Aroostook Medical Center to Enhance Nurse Understanding of the Professional Role 2Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:Better Life Maids of Portland Oregon Prepares For a Summer of 2013 Launch 2Health News:Automated Security Alert's New Medical Alarm Works Even In Power Outages 2
... ... titanium ring studios shows that single women shop for engagement rings before meeting the partner they ... ... design studios, TiRings.com, has revealed evidence that shows a tendency among single women to shop for ...
... ... is the leading supplier of software & technology to Home Medical ... Health Care Agencies. Only Fastrack offers a solution for each ... virtually every clinical, operational and financial aspect of a provider’s business, ...
... The ... and other metal products. In addition to revealing the personality and culture of The Monterey ... pins, and an informal forum for discussions related to such products. , ... (PRWEB) May 8, 2010 -- This year has been a ...
... carbonated soft drinks is not associated with the risk of ... 7 in the Journal of the National Cancer Institute. ... and tea may lower the risk of cancer, but others ... contains anti-oxidants that in theory help prevent cancer but also ...
... ... Beauty, Fighting the Aging Process and Maintaining a Youthful, “Close-Up-Ready” Appearance , ... Los Angeles, CA (PRWEB) May ... have begun to open up about using non-surgical aesthetic procedures to maintain their youthful, ...
... ... religion’s first book this weekend. Published May 9, 1950, “Dianetics: The Modern Science of ... , ... 2010 -- Churches of Scientology around the world celebrate the original release of ...
Cached Medicine News:Health News:Statistics Reveal Women Choose Engagement Rings Before Men 2Health News:Fastrack Acquires Prometheus Group Industry Leading HME Billing Service 2Health News:Monterey Lapel Pin Company Continues Its Website Evolution 2Health News:Monterey Lapel Pin Company Continues Its Website Evolution 3Health News:Coffee and soft drinks have little or no association with colon cancer risk 2Health News:Achieve Hollywood Glamour with Non-Surgical Cosmetic Procedures 2Health News:Achieve Hollywood Glamour with Non-Surgical Cosmetic Procedures 3Health News:Scientology Churches Celebrate Dianetics 60th Anniversary 2
(Date:5/23/2013)... DIEGO and PARIS , ... VOLC ), a leading developer and manufacturer of precision ... treatment of coronary and peripheral vascular disease, today announced ... V asodilator I ndependent S tenosis ... breaking clinical trial session at EuroPCR 2013. These prospective ...
(Date:5/23/2013)... -- Nederland keurt als eerste nieuwe vaste-dosis ... BPH Astellas Pharma EUROPE ... gebaseerd in Tokyo  ( ... Nederlandse College ter Beoordeling van Geneesmiddelen (CBG) een handelsvergunning ... handelsvergunning verleend voor VESOMNI is voor "de behandeling van ...
(Date:5/23/2013)... , Switzerland and ... 2013 Cenix BioScience, a ... specialized in RNAi-, miRNA- and high content-driven pharmacology, ... group of companies with a focus on the ... needs, including oncology and companion diagnostics, today announced ...
Breaking Medicine Technology:Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4
... PARSIPPANY, N.J. , June 28 Preliminary ... with diabetes and hypertension demonstrated that the investigational triple ... (40/10/25 mg) resulted in a statistically significant greater Least ... at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm ...
... , June 28 Codexis, Inc. (Nasdaq: CDXS ... company as Senior Vice President, Commercial Operations, a new position.  Mr. ... operations worldwide.  He will report to Joseph Sarret , M.D., ... , , , ...
Cached Medicine Technology:New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 2New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 3New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 4New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 5New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 6New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 7Codexis Names Peter Strumph SVP, Commercial Operations 2
... 1-step, hand-held, point-of-care device for the qualitative detection ... The TOX/See device can detect up to ... 3 to 8 minutes and requires only a ... individually packaged to maximize convenience and ease of ...
... point-of-care device for the qualitative detection of drug ... TOX/See device can detect up to nine of ... 8 minutes and requires only a few drops ... to maximize convenience and ease of use. TOX/See ...
... hand-held, point-of-care device for the qualitative detection of ... The TOX/See device can detect up to nine ... to 8 minutes and requires only a few ... packaged to maximize convenience and ease of use. ...
... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
Medicine Products: